A recombinant antibody in which at least the constant regions in the heavy chain and the light chain have been converted into human-origin regions and which inhibits the binding of an integrin recognizing the RGD sequence to osteopontinor its fragment and inhibits the binding of an integrin recognizing the SVVYGLR sequence or a sequence corresponding thereto to osteopontin or its fragment. This antibody is useful as a remedy for autoimmune diseases and a remedy for rheumatism or rheumatoid arthritis.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-0258CL | Anti-Human SPP1 Recombinant Antibody (mAb 4-4-2) | ELISA, WB | |
TAB-0259CL | Anti-Human SPP1 Recombinant Antibody (mAb 7-5-4) | ELISA, WB | |
TAB-0260CL | Anti-Human SPP1 Recombinant Antibody (mAb 9-3-1) | ELISA, WB | |
TAB-0261CL | Anti-Human SPP1 Recombinant Antibody (mAb 21-5-4) | ELISA, WB | |
TAB-0843CL-S(P) | Anti-Human SPP1 Recombinant Antibody scFv Fragment (2K1) | sELISA |
There are currently no Customer reviews or questions for HPAB-0069-YC-F(E). Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.